Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of Doxorubicin.

Palazzolo S, Hadla M, Spena CR, Bayda S, Kumar V, Lo Re F, Adeel M, Caligiuri I, Romano F, Corona G, Canzonieri V, Toffoli G, Rizzolio F.

ACS Med Chem Lett. 2019 Jan 31;10(4):517-521. doi: 10.1021/acsmedchemlett.8b00557. eCollection 2019 Apr 11.

PMID:
30996789
2.

Potent In Vitro and In Vivo Anticancer Activity of New Bipyridine and Bipyrimidine Gold (III) Dithiocarbamate Derivatives.

Altaf M, Casagrande N, Mariotto E, Baig N, Kawde AN, Corona G, Larcher R, Borghese C, Pavan C, Seliman AA, Aldinucci D, Isab AA.

Cancers (Basel). 2019 Apr 4;11(4). pii: E474. doi: 10.3390/cancers11040474.

3.

Complete and Durable Response to Combined Chemo/Radiation Therapy in EGFR Wild-Type Lung Adenocarcinoma with Diffuse Brain Metastases.

Santeufemia DA, Palmieri G, Cossu A, De Re V, Caggiari L, De Zorzi M, Casula M, Sini MC, Baldino G, Dedola MF, Corona G, Miolo G.

Diagnostics (Basel). 2019 Apr 11;9(2). pii: E42. doi: 10.3390/diagnostics9020042.

4.

The metabolomic scent of cancer disease progression in soft tissue sarcoma: A case report.

Miolo G, Basile D, Carretta A, Santeufemia DA, Steffan A, Corona G.

Int J Biol Markers. 2019 Mar 11:1724600818817316. doi: 10.1177/1724600818817316. [Epub ahead of print]

PMID:
30852948
5.

Clinical outcomes of oral metronomic vinorelbine in advanced non-small cell lung cancer: correlations with pharmacokinetics and MDR1 polymorphisms.

Gusella M, Pasini F, Caruso D, Barile C, Modena Y, Fraccon AP, Bertolaso L, Menon D, Crepaldi G, Bononi A, Spezzano R, Telatin GA, Corona G, Padrini R.

Cancer Chemother Pharmacol. 2019 Mar;83(3):493-500. doi: 10.1007/s00280-018-3751-0. Epub 2018 Dec 12.

PMID:
30542768
6.

Oral Metronomic Vinorelbine (OMV) in elderly or pretreated patients with advanced non small cell lung cancer: outcome and pharmacokinetics in the real world.

Pasini F, Barile C, Caruso D, Modena Y, Fraccon AP, Bertolaso L, Menon D, La Russa F, Crepaldi G, Bononi A, Spezzano R, Padrini R, Corona G, Gusella M.

Invest New Drugs. 2018 Oct;36(5):927-932. doi: 10.1007/s10637-018-0631-8. Epub 2018 Jun 28.

PMID:
29956056
7.

Rapid LC-MS/MS method for quantification of vinorelbine and 4-O-deacetylvinorelbine in human whole blood suitable to monitoring oral metronomic anticancer therapy.

Corona G, Gusella M, Gaspardo A, Miolo G, Bertolaso L, Pezzolo E, Pasini F, Steffan A, Caruso D.

Biomed Chromatogr. 2018 May 10:e4282. doi: 10.1002/bmc.4282. [Epub ahead of print]

PMID:
29749011
8.

Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer.

Russo Spena C, De Stefano L, Palazzolo S, Salis B, Granchi C, Minutolo F, Tuccinardi T, Fratamico R, Crotti S, D'Aronco S, Agostini M, Corona G, Caligiuri I, Canzonieri V, Rizzolio F.

J Control Release. 2018 Jul 10;281:1-10. doi: 10.1016/j.jconrel.2018.04.055. Epub 2018 May 8.

PMID:
29746956
9.

Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.

Corona G, Cannizzaro R, Miolo G, Caggiari L, De Zorzi M, Repetto O, Steffan A, De Re V.

Int J Mol Sci. 2018 Mar 7;19(3). pii: E750. doi: 10.3390/ijms19030750.

10.

Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.

Bayda S, Hadla M, Palazzolo S, Riello P, Corona G, Toffoli G, Rizzolio F.

Curr Med Chem. 2018;25(34):4269-4303. doi: 10.2174/0929867325666171229141156. Review.

PMID:
29284391
11.

A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach.

Caggiari L, Miolo G, Canzonieri V, De Zorzi M, Alessandrini L, Corona G, Cannizzaro R, Santeufemia DA, Cossu A, Buonadonna A, De Re V.

Cancer Biol Ther. 2018 Apr 3;19(4):254-259. doi: 10.1080/15384047.2017.1394540. Epub 2017 Nov 13.

12.

The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.

Palazzolo S, Bayda S, Hadla M, Caligiuri I, Corona G, Toffoli G, Rizzolio F.

Curr Med Chem. 2018;25(34):4224-4268. doi: 10.2174/0929867324666170830113755. Review.

PMID:
28875844
13.

Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy.

Bayda S, Hadla M, Palazzolo S, Kumar V, Caligiuri I, Ambrosi E, Pontoglio E, Agostini M, Tuccinardi T, Benedetti A, Riello P, Canzonieri V, Corona G, Toffoli G, Rizzolio F.

J Control Release. 2017 Feb 28;248:144-152. doi: 10.1016/j.jconrel.2017.01.022. Epub 2017 Jan 14.

PMID:
28093297
14.

New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.

Altaf M, Monim-Ul-Mehboob M, Kawde AN, Corona G, Larcher R, Ogasawara M, Casagrande N, Celegato M, Borghese C, Siddik ZH, Aldinucci D, Isab AA.

Oncotarget. 2017 Jan 3;8(1):490-505. doi: 10.18632/oncotarget.13448.

15.

Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer.

Miolo G, Muraro E, Caruso D, Crivellari D, Ash A, Scalone S, Lombardi D, Rizzolio F, Giordano A, Corona G.

Oncotarget. 2016 Jun 28;7(26):39809-39822. doi: 10.18632/oncotarget.9489.

16.

Association of the germline BRCA2 missense variation Glu2663Lys with high sensitivity to trabectedin-based treatment in soft tissue sarcoma.

Miolo G, Viel A, Canzonieri V, Baresic T, Buonadonna A, Santeufemia DA, Lara DP, Corona G.

Cancer Biol Ther. 2016 Oct 2;17(10):1017-1021.

17.

Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models.

Hadla M, Palazzolo S, Corona G, Caligiuri I, Canzonieri V, Toffoli G, Rizzolio F.

Nanomedicine (Lond). 2016 Sep;11(18):2431-41. doi: 10.2217/nnm-2016-0154. Epub 2016 Aug 25.

PMID:
27558906
18.

Gonadal agenesis with hypoplastic paramesonephric ducts (PMNDs) derivatives in dizygotic twins.

Miolo G, Del Pup L, Ash A, Manno M, Pivetta B, Tessitori G, Corona G.

Gynecol Endocrinol. 2016 Oct;32(10):792-795. Epub 2016 Jul 5.

PMID:
27379817
19.

DNA Nanotechnology for Cancer Therapy.

Kumar V, Palazzolo S, Bayda S, Corona G, Toffoli G, Rizzolio F.

Theranostics. 2016 Mar 20;6(5):710-25. doi: 10.7150/thno.14203. eCollection 2016. Review.

20.

Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin.

Toffoli G, Hadla M, Corona G, Caligiuri I, Palazzolo S, Semeraro S, Gamini A, Canzonieri V, Rizzolio F.

Nanomedicine (Lond). 2015 Oct;10(19):2963-2971. doi: 10.2217/nnm.15.118. Epub 2015 Sep 30.

PMID:
26420143

Supplemental Content

Loading ...
Support Center